Neuren Pharmaceuticals Ltd (NEU) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.397x

Based on the latest financial reports, Neuren Pharmaceuticals Ltd (NEU) has a cash flow conversion efficiency ratio of 0.397x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$128.31 Million ≈ $90.78 Million USD) by net assets (AU$323.27 Million ≈ $228.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Neuren Pharmaceuticals Ltd worth for the company's overall valuation and market capitalisation.

Neuren Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Neuren Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neuren Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neuren Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Explore NEU cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sixth Street Specialty Lending Inc NYSE:TSLX	0.025x
China Publishing & Media Hldg SHG:601949	0.023x
Kelington Group Bhd KLSE:0151	-0.065x
Monarch Casino & Resort Inc NASDAQ:MCRI	0.104x
Zhengzhou GL Tech Co Ltd SHE:300480	-0.004x
Solvac S.A. BR:SOLV	0.011x
GCS Holdings TWO:4991	0.100x
Bank of Chongqing Co Ltd F:CQN	-0.075x

Annual Cash Flow Conversion Efficiency for Neuren Pharmaceuticals Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Neuren Pharmaceuticals Ltd from 2002 to 2024. View NEU stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$363.90 Million ≈ $257.49 Million	AU$-11.27 Million ≈ $-7.97 Million	-0.031x	-103.44%
2023-12-31	AU$205.21 Million ≈ $145.20 Million	AU$184.93 Million ≈ $130.85 Million	0.901x	+941.36%
2022-12-31	AU$41.59 Million ≈ $29.43 Million	AU$3.60 Million ≈ $2.55 Million	0.087x	+134.07%
2021-12-31	AU$39.25 Million ≈ $27.77 Million	AU$-9.97 Million ≈ $-7.05 Million	-0.254x	+23.91%
2020-12-31	AU$24.20 Million ≈ $17.12 Million	AU$-8.08 Million ≈ $-5.72 Million	-0.334x	+60.56%
2019-12-31	AU$13.85 Million ≈ $9.80 Million	AU$-11.72 Million ≈ $-8.29 Million	-0.846x	-425.81%
2018-12-31	AU$24.67 Million ≈ $17.45 Million	AU$6.41 Million ≈ $4.53 Million	0.260x	+176.04%
2017-12-31	AU$16.36 Million ≈ $11.58 Million	AU$-5.59 Million ≈ $-3.96 Million	-0.342x	+88.46%
2016-12-31	AU$4.18 Million ≈ $2.96 Million	AU$-12.38 Million ≈ $-8.76 Million	-2.959x	-234.75%
2015-12-31	AU$14.40 Million ≈ $10.19 Million	AU$-12.73 Million ≈ $-9.01 Million	-0.884x	-163.10%
2014-12-31	AU$19.08 Million ≈ $13.50 Million	AU$-6.41 Million ≈ $-4.54 Million	-0.336x	-6.14%
2013-12-31	AU$24.36 Million ≈ $17.23 Million	AU$-7.71 Million ≈ $-5.45 Million	-0.317x	+31.96%
2012-12-31	AU$6.34 Million ≈ $4.49 Million	AU$-2.95 Million ≈ $-2.09 Million	-0.465x	-40.59%
2011-12-31	AU$9.45 Million ≈ $6.69 Million	AU$-3.13 Million ≈ $-2.21 Million	-0.331x	+59.31%
2010-12-31	AU$3.53 Million ≈ $2.50 Million	AU$-2.87 Million ≈ $-2.03 Million	-0.813x	-364.34%
2009-12-31	AU$7.35 Million ≈ $5.20 Million	AU$-1.29 Million ≈ $-910.66K	-0.175x	+89.20%
2008-12-31	AU$5.57 Million ≈ $3.94 Million	AU$-9.04 Million ≈ $-6.40 Million	-1.622x	-6.50%
2007-12-31	AU$7.55 Million ≈ $5.34 Million	AU$-11.50 Million ≈ $-8.14 Million	-1.523x	-169.10%
2006-12-31	AU$16.15 Million ≈ $11.42 Million	AU$-9.14 Million ≈ $-6.47 Million	-0.566x	-116.92%
2005-12-31	AU$32.16 Million ≈ $22.75 Million	AU$-8.39 Million ≈ $-5.94 Million	-0.261x	+37.81%
2004-12-31	AU$8.77 Million ≈ $6.20 Million	AU$-3.68 Million ≈ $-2.60 Million	-0.420x	-232.00%
2003-12-31	AU$-14.72 Million ≈ $-10.41 Million	AU$-4.68 Million ≈ $-3.31 Million	0.318x	+111.17%
2002-12-31	AU$1.82 Million ≈ $1.29 Million	AU$-5.19 Million ≈ $-3.67 Million	-2.846x	--

About Neuren Pharmaceuticals Ltd

AU:NEU Australia Biotechnology

Market Cap

$1.85 Billion

AU$2.62 Billion AUD

Market Cap Rank

#6811 Global

#161 in Australia

Share Price

AU$20.68

Change (1 day)

+0.68%

52-Week Range

AU$11.28 - AU$23.64

All Time High

AU$25.11